Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
210.60    3.00 (1.45%)
Bid:
209.80
Ask:
210.20
Spread: 0.40 (0.191%)
Market Cap: £916.68m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

HS2 Site Visit

24 May 2023 07:00

RNS Number : 4016A
Kier Group PLC
24 May 2023
 

24 May 2023

 

 

Kier Group plc

HS2 Site Visit

 

Kier Group plc ("Kier" or "the Group"), a leading UK infrastructure services, construction and property group is hosting a site visit this morning to High Speed Rail Two ("HS2") for analysts and institutional investors. It will include a presentation on Kier's capabilities as part of the Eiffage, Kier, Ferrovial Construction and BAM Nuttall ("EKFB") joint venture.

 

No material new information or update on trading will be provided.

 

 

- ENDS -

 

 

 

For further information, please contact: 

Investor Relations

+44 (0)7933 388 746

Kier Press Office

+44 (0)1767 355 096

Richard Mountain, FTI Consulting

+44 (0)203 727 1340

 

 

About Kier Group plc

Kier is a leading UK infrastructure and construction services group. We provide specialist design and build capabilities and the knowledge, skills and intellectual capital of our people to ensure we are able to project manage and integrate all aspects of a project.

 

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2022 for a further discussion of the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUGAAUPWGAW
Date   Source Headline
15th Oct 202111:43 amRNSAnnual Financial Report
5th Oct 202111:04 amRNSDirector/PDMR Shareholding
30th Sep 20219:33 amRNSHolding(s) in Company
21st Sep 20212:17 pmRNSDirector/PDMR Shareholding
20th Sep 20214:52 pmRNSHolding(s) in Company
16th Sep 20217:00 amRNSResults for the year ended 30 June 2021
9th Sep 202111:00 amRNSHolding(s) in Company
2nd Sep 202111:22 amRNSHolding(s) in Company
1st Sep 20218:52 amRNSTotal Voting Rights
31st Aug 20214:07 pmRNSHolding(s) in Company
23rd Aug 20211:05 pmRNSHolding(s) in Company
20th Aug 202110:27 amRNSDirector/PDMR Shareholding
2nd Aug 20219:27 amRNSTotal Voting Rights
23rd Jul 202111:46 amRNSDirector/PDMR Shareholding
23rd Jul 20219:36 amRNSHolding(s) in Company
13th Jul 20217:00 amRNSFull Year 2021 Trading Update
13th Jul 20217:00 amRNSFull Year 2021 Trading Update
1st Jul 20219:05 amRNSBlock listing Interim Review
1st Jul 20218:36 amRNSTotal Voting Rights
25th Jun 20214:41 pmRNSHolding(s) in Company
22nd Jun 20214:05 pmRNSHolding(s) in Company
21st Jun 20213:59 pmRNSDirector/PDMR Shareholding
21st Jun 20212:59 pmRNSHolding(s) in Company
18th Jun 20212:30 pmRNSDirector/PDMR Shareholding
18th Jun 20219:47 amRNSDirector/PDMR Shareholding
18th Jun 20218:30 amRNSHolding(s) in Company
18th Jun 20217:00 amRNSAdmission to trading and notice of trading update
17th Jun 20214:07 pmRNSHolding(s) in Company
16th Jun 202110:17 amRNSResult of Meeting
15th Jun 20218:11 amRNSResult of Open Offer
28th May 20212:56 pmRNSCompletion of the sale of Kier Living
14th May 20214:30 pmRNSDirector/PDMR Shareholding
13th May 20215:36 pmRNSPublication of Prospectus and Notice of GM
13th May 20213:34 pmRNSSuccessful completion of Accelerated Bookbuild
13th May 20217:00 amRNSProposed c.£241 million Capital Raise
7th May 202110:29 amRNSResult of Meeting
5th May 20217:00 amRNSExecutive Appointments
21st Apr 20217:00 amRNSResults for the six months ended 31 December 2020
20th Apr 20215:02 pmRNSNotice of GM
16th Apr 20215:01 pmRNSSale of Kier Living
12th Apr 202111:52 amRNSDirector/PDMR Shareholding
19th Mar 20213:07 pmRNSDirector/PDMR Shareholding
22nd Feb 20214:37 pmRNSDirector/PDMR Shareholding
16th Feb 20216:15 pmRNSDirector Declaration
1st Feb 20217:17 amRNSDirector Declaration
19th Jan 20212:12 pmRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSTrading update
13th Jan 20219:04 amRNSBlock listing Interim Review
21st Dec 202012:32 pmRNSDirector/PDMR Shareholding
21st Dec 20207:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.